| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.05 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.06 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |